Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 780 of 1,261
  1. US 8900616

    System and method for satellite drug delivery

    Covidien LP · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  2. US 8900862

    Mesh enclosed tissue constructs

    The Regents of the University of California · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  3. US 8900574

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  4. US 8900555

    Insulin derivative formulations for pulmonary delivery

    Nektar Therapeutics · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  5. CA 2912973

    BIOMARQUEURS D'EXPRESSION DE GENES ET LEUR UTILISATION POUR DES APPLICATIONS DIAGNOSTIQUES ET PRONOSTIQUES CHEZ DES PATIENTS NECESSITANT EVENTUELLEMENT UN TRAITEMENT FAISANT INTER VENIR UN INHIBITEUR DE HDAC

    4SC AG [DE] · Granted Nov 27, 2014 · Expires Nov 22, 2034

    granted
  6. EP 2804734

    GITTERVERLUSTREDUKTION BEI PFLASTERHERSTELLUNG

    ACINO AG [DE] · Granted Nov 26, 2014 · Expires Nov 21, 2034

    granted
  7. US 8895755

    Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity

    Theravance Biopharma R&D IP, LLC · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  8. US 8895536

    Compositions and methods for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  9. US 8895722

    Splice-region antisense composition and method

    Sarepta Therapeutics, Inc. · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  10. US 8895521

    Methods and compositions for the treatment of uveitis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  11. US 8895539

    Pregnancy hormone combination for treatment of autoimmune diseases

    The Regents of the University of California · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  12. US 8895588

    Pyrazole compound

    Takeda Pharmaceutical Company Limited · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  13. US 8895579

    Heterotricyclic AMPA receptor antagonists for treatment of epilepsy, pain, and other neurological disorders and diseases

    Northwestern University · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  14. US 8895578

    Carboxamide, sulfonamide and amine compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  15. US 8895553

    Oligomer-containing substituted aromatic triazine compounds

    Nektar Therapeutics · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  16. US 8895537

    Compositions and methods for treating cardiovascular diseases

    Infirst Healthcare Limited · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  17. US 8895717

    Delivery of siRNA by neutral lipid compositions

    The Board of Regents of the University of Texas System · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  18. US 8895242

    Single molecule nucleic acid nanoparticles

    The Regents of the University of California · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  19. US 8895078

    Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts

    BIONORICA ETHICS GMBH · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  20. US 8895072

    Quantum dot barcode structures and uses thereof

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  21. US 8895759

    Intermediates useful in the preparation of maleimide functionalized polymers

    Nektar Therapeutics · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  22. US 8895018

    Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

    The United States of America as represented by the Department of Veteran Affairs · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  23. US 8895723

    Methods of preparing substituted nucleotide analogs

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  24. US 8895055

    Telodendrimer nanodiscs without apolipoprotein

    The Regents of the University of California · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.